Register your study with ISRCTN today!
Dear Prof CERASALE MORTEO,
Registration of clinical trials and other studies is the first step towards transparency and the future dissemination of research outcomes.
An increasing number of journals, including Journal of Hematology & Oncology, Molecular Cancer and BMC Cancer, require registration before publication of the protocol and/or the results.
The ISRCTN registry administered by BioMed Central accepts all study designs involving human subjects.
Why not register your study with us today?
The ISRCTN registry, administered by BioMed Central, accepts all study designs involving human subjects, whether interventional or observational, proposed or completed or ongoing.
Featured related blog post
World Cancer Day is an international event that aims to unite the world against cancer. Here at the ISRCTN registry, we are showing our support by exploring some of the research we have registered in this field.
Why register with ISRCTN?
Best wishes,
The ISRCTN Team
Don’t forget to follow @ISRCTN on Twitter, and you can always email us at info@isrctn.com with any enquiries you may have.
|
For further information or enquiries please contact Customer Services at:info@biomedcentral.com.
BioMed Central Ltd
236 Gray's Inn Road, London, WC1X 8HB,
United Kingdom.
No hay comentarios:
Publicar un comentario